Asian share markets fell on Thursday as concerns that tensions over Hong Kong may stymie a U.S.-China trade deal cast a pall over Thanksgiving cheer from positive U.S. economic data.
Global Markets: Asian shares climb on prospects of trade progress, low rates
Asian shares ticked higher on Wednesday as more upbeat signals from Sino-U.S. trade talks fanned hopes of an imminent end to tariff hostilities, which helped offset concerns about a slowing U.S. economy.
Global Markets: Asian shares climb on prospects of trade progress, low rates
Asian shares ticked higher on Wednesday as more upbeat signals from Sino-U.S. trade talks fanned hopes of an imminent end to tariff hostilities, which helped offset concerns about a slowing U.S. economy.
Trade hopes lift dollar, rate cut forecast hobbles Aussie
The dollar posted modest gains on Wednesday, as traders looked ahead to a possible outcome to drawn out U.S.-China trade talks, while a forecast for monetary policy easing knocked the Aussie.
It’s not just trade hopes fueling the U.S. stocks rally
Wall Street stocks have leap-frogged over a host of concerns, including a stall in corporate earnings and political controversy in Washington, on their way to record highs this month.
Gold eases on prospect of U.S.-China trade war truce
Gold fell to a two-week low on Tuesday as talks between top negotiators from the United States and China boosted prospects that an interim trade deal could be reached soon, denting demand for the safe-haven metal.
Singapore’s Hyflux strikes $300 million rescue deal with UAE’s Utico
Embattled Singapore water firm Hyflux said on Tuesday it had entered a restructuring deal worth S$400 million ($293 million) with United Arab Emirates-based utility Utico FZC.
Fiat Chrysler, PSA tell employees they will sign merger agreement in coming weeks – media
Fiat Chrysler and Peugeot-owner PSA told their employees they would sign a binding merger agreement in coming weeks, several Italian newspapers reported on Tuesday.
Novartis nears deal to buy U.S. biotech firm Medicines Co for about $7 billion – WSJ
Swiss drugmaker Novartis AG is nearing an agreement to acquire U.S. biotechnology firm The Medicines Co for about $7 billion, the Wall Street Journal reported on Saturday.
No ‘phase two’ U.S.-China deal on the horizon, officials say
An ambitious “phase two” trade deal between the United States and China is looking less likely as the two countries struggle to strike a preliminary “phase one” agreement, according to U.S. and Beijing officials, lawmakers and trade experts.